| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acquired EGFR L718V mutation mediates resistance to osimertinib in non-small cell lung cancer but retains sensitivity to afatinib
|
Liu, Yutao
|
|
2018
|
118 |
C |
p. 1-5
|
artikel
|
| 2 |
Challenges and future direction of molecular research in air pollution-related lung cancers
|
Shahadin, Maizatul Syafinaz
|
|
2018
|
118 |
C |
p. 69-75
|
artikel
|
| 3 |
Clinical analysis by next-generation sequencing for NSCLC patients with MET amplification resistant to osimertinib
|
Wang, Yubo
|
|
2018
|
118 |
C |
p. 105-110
|
artikel
|
| 4 |
Clinicopathological characteristics of POLE mutation in patients with non-small-cell lung cancer
|
Song, Zhengbo
|
|
2018
|
118 |
C |
p. 57-61
|
artikel
|
| 5 |
Combined effect of ERCC1 and ERCC2 polymorphisms on overall survival in non-squamous non-small-cell lung cancer patients treated with first-line pemetrexed/platinum
|
Liao, Wei-Yu
|
|
2018
|
118 |
C |
p. 90-96
|
artikel
|
| 6 |
Contents
|
|
|
2018
|
118 |
C |
p. v-vi
|
artikel
|
| 7 |
Early Contrast Enhancement: A novel magnetic resonance imaging biomarker of pleural malignancy
|
Tsim, Selina
|
|
2018
|
118 |
C |
p. 48-56
|
artikel
|
| 8 |
Editorial Board
|
|
|
2018
|
118 |
C |
p. iii
|
artikel
|
| 9 |
Eribulin inhibits the growth of small cell lung cancer cell lines alone and with radiotherapy
|
Helfrich, Barbara A.
|
|
2018
|
118 |
C |
p. 148-154
|
artikel
|
| 10 |
Heterotopic production of ceruloplasmin by lung adenocarcinoma is significantly correlated with prognosis
|
Matsuoka, Ryota
|
|
2018
|
118 |
C |
p. 97-104
|
artikel
|
| 11 |
High expression of P-cadherin is significantly associated with poor prognosis in patients with non-small-cell lung cancer
|
Imai, Sachiko
|
|
2018
|
118 |
C |
p. 13-19
|
artikel
|
| 12 |
Histology significantly affects recurrence and survival following SBRT for early stage non-small cell lung cancer
|
Baine, Michael J.
|
|
2018
|
118 |
C |
p. 20-26
|
artikel
|
| 13 |
Identification of a novel KIF13A-RET fusion in lung adenocarcinoma by next-generation sequencing
|
Zhang, Xuefei
|
|
2018
|
118 |
C |
p. 27-29
|
artikel
|
| 14 |
Is heterogeneity in stage 3 non-small cell lung cancer obscuring the potential benefits of dose-escalated concurrent chemo-radiotherapy in clinical trials?
|
Hudson, Andrew
|
|
2018
|
118 |
C |
p. 139-147
|
artikel
|
| 15 |
MiR-192 and miR-662 enhance chemoresistance and invasiveness of squamous cell lung carcinoma
|
Filipska, Martyna
|
|
2018
|
118 |
C |
p. 111-118
|
artikel
|
| 16 |
Neoadjuvant treatment followed by surgery versus definitive chemoradiation in stage IIIA-N2 non-small-cell lung cancer: A multi-institutional study by the oncologic group for the study of lung cancer (Spanish Radiation Oncology Society)
|
Couñago, F.
|
|
2018
|
118 |
C |
p. 119-127
|
artikel
|
| 17 |
Optimal surgical approach to thymic malignancies: New trends challenging old dogmas
|
Ruffini, Enrico
|
|
2018
|
118 |
C |
p. 161-170
|
artikel
|
| 18 |
PD-L1 expression in large cell neuroendocrine carcinoma of the lung
|
Eichhorn, F.
|
|
2018
|
118 |
C |
p. 76-82
|
artikel
|
| 19 |
PD-L1 expression in lung adenocarcinoma harboring EGFR mutations or ALK rearrangements
|
Yoneshima, Yasuto
|
|
2018
|
118 |
C |
p. 36-40
|
artikel
|
| 20 |
Phase II trial of preoperative pemetrexed plus carboplatin in patients with stage IB-III nonsquamous non-small cell lung cancer (NSCLC)
|
Hainsworth, John D.
|
|
2018
|
118 |
C |
p. 6-12
|
artikel
|
| 21 |
Pre-operative quantification of pulmonary function using hybrid-SPECT/low-dose-CT: A pilot study
|
Genseke, Philipp
|
|
2018
|
118 |
C |
p. 155-160
|
artikel
|
| 22 |
Prognostic significance of 18F-fluorodeoxyglucose uptake of bone marrow measured on positron emission tomography in patients with small cell lung cancer
|
Lee, Jeong Won
|
|
2018
|
118 |
C |
p. 41-47
|
artikel
|
| 23 |
Programmed cell death-ligand 1 (PD-L1) expression is associated with RAS/TP53 mutations in lung adenocarcinoma
|
Serra, Pierre
|
|
2018
|
118 |
C |
p. 62-68
|
artikel
|
| 24 |
Response to crizotinib in advanced ALK-rearranged non-small cell lung cancers with different ALK-fusion variants
|
Li, Yan
|
|
2018
|
118 |
C |
p. 128-133
|
artikel
|
| 25 |
Surface marker profiles on lung lymphocytes may predict the mechanism of immune-mediated pneumonitis triggered by tumor-infiltrating lymphocytes in lung cancer patients treated with pembrolizumab
|
Oda, Keishi
|
|
2018
|
118 |
C |
p. 171-172
|
artikel
|
| 26 |
The eighth TNM classification system for lung cancer: A consideration based on the degree of pleural invasion and involved neighboring structures
|
Sakakura, Noriaki
|
|
2018
|
118 |
C |
p. 134-138
|
artikel
|
| 27 |
The ratio of cancer cells to stroma within the invasive area is a histologic prognostic parameter of lung adenocarcinoma
|
Ichikawa, Tomohiro
|
|
2018
|
118 |
C |
p. 30-35
|
artikel
|
| 28 |
Uncommon EGFR G724S mutations arise in non-small-cell lung cancer patients with acquired resistance to first-generation EGFR-TKIs
|
Li, Jun
|
|
2018
|
118 |
C |
p. 173-175
|
artikel
|
| 29 |
What CT characteristics of lepidic predominant pattern lung adenocarcinomas correlate with invasiveness on pathology?
|
Aherne, Emily A.
|
|
2018
|
118 |
C |
p. 83-89
|
artikel
|
Tijdschrift beschrijving